Disclosure Document for an 18 U

First Page		Document Content
Date: 2006-11-14 08:23:20 Arthritis Connective tissue diseases COX-2 inhibitors Dow Jones Industrial Average Celecoxib G. D. Searle & Company Rheumatoid arthritis Juvenile idiopathic arthritis Non-steroidal anti-inflammatory drug Health Medicine Pfizer		Disclosure Document for an 18 U Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 12,97 KB Share Document on Facebook

	HEALTHNET NEWS A newsletter for public librarians and others interested in consumer health information services Volume XVI I Number 1 DocID: 1qcqN - View Document
	Staying Healthy, July 2016 July Observance: Juvenile Arthritis Awareness Month What is juvenile arthritis/juvenile idiopathic arthritis (JA/JIA)? Many people don’t know that kids get arthritis. A child’s immune syste DocID: 1q1Mi - View Document
	THE DEFENSIVE ARRANGEMENTS OF THE BODY AS ILLUSTRATED BY THE … INCIDENCE OF DISEASE IN CHILDREN AND ADULTS. The Wightman Lecture for 1908 By SIR WATSON CHEYNE, BT., C.B., F.R.S., Senior Surgeon at King’s College Hosp DocID: 1ouLH - View Document
	Osteoarthritis There are different types of arthritis; here we will be focusing on Osteoarthritis (OA), also known as Degenerative Joint Disease (DJD). DocID: 1nqCu - View Document
	Company Background In 2004, Stephanie Tobor learned that her 3-year-old daughter had Juvenile Idiopathic Arthritis and that environmental pollutants are known to contribute to the illness. With the understanding that vol DocID: 1kwHS - View Document